Clinical Trials
2 trialsNCT00004941 2015-03-25
Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease
FDA Office of Orphan Products Development
Phase 3 Completed
NCT00427804 2013-02-04
Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption
Atlanta VA Medical Center
Phase NA Completed